Literature DB >> 22875288

Cocaine-induced vasculitis: clinical and immunological spectrum.

Luis R Espinoza1, Rodolfo Perez Alamino.   

Abstract

Levamisole-contaminated cocaine has recently been recognized in North America and Europe, and its use is associated with a variety of clinical and autoimmune abnormalities. The clinical characteristic seems to be the presence of a painful purpuric skin rash that predominantly affects the ear lobes and cheeks, often accompanied by systemic manifestations including fever, malaise, arthralgias, myalgias, and laboratory abnormalities, for example leukopenia, neutropenia, positive ANA, ANCA, and phospholipid antibodies. Most of these manifestations can be seen with the use of either drug, especially levamisole. There is no specific therapy, and discontinuation of its use is followed by improvement. Prednisone and immunosuppressive therapy may be needed at times. Further use of the drug is characterized by recurrence of most of the complaints.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875288     DOI: 10.1007/s11926-012-0283-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  50 in total

Review 1.  Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole.

Authors:  Jennie A Buchanan; Eric J Lavonas
Journal:  Curr Opin Hematol       Date:  2012-01       Impact factor: 3.284

2.  Cocaine-related Stevens-Johnson syndrome.

Authors:  G F Hofbauer; G Burg; F O Nestle
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

3.  Recurrent leukoencephalopathy in a cocaine abuser.

Authors:  Federico Bianco; Elisa Iacovelli; Emanuele Tinelli; Chiara Lepre; Flavia Pauri
Journal:  Neurotoxicology       Date:  2011-03-22       Impact factor: 4.294

Review 4.  Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement.

Authors:  Angela Wolford; Thomas S McDonald; Heather Eng; Steven Hansel; Yue Chen; Jonathan Bauman; Raman Sharma; Amit S Kalgutkar
Journal:  Drug Metab Dispos       Date:  2012-03-05       Impact factor: 3.922

5.  Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome.

Authors:  Jun Oh; Markus J Kemper
Journal:  Expert Rev Clin Pharmacol       Date:  2010-07       Impact factor: 5.045

6.  Necrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole.

Authors:  Russell W Farmer; Paula S Malhotra; Michael P Mays; Michael E Egger; Jason W Smith; Saeed A Jortani; Henry Spiller; George M Bosse; Jeffrey P Callen; Glen A Franklin
Journal:  J Burn Care Res       Date:  2012 Jan-Feb       Impact factor: 1.845

7.  Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.

Authors:  Bent Ejlertsen; Henning T Mouridsen; Maj-Britt Jensen; Jørn Andersen; Michael Andersson; Claus Kamby; Ann S Knoop
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

8.  Neutropenia during treatment of rheumatoid arthritis with levamisole.

Authors:  G T Williams; S A Johnson; P A Dieppe; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1978-08       Impact factor: 19.103

9.  Left kidney: an unusual site of cocaine-related renal infarction. A case report.

Authors:  F Fabbian; M Pala; A De Giorgi; R Tiseo; C Molino; A Mallozzi Menegatti; F Travasoni; E Misurati; F Portaluppi; R Manfredini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-03       Impact factor: 3.507

10.  Cocaine-related vasculitis causing scrotal gangrene.

Authors:  Szu-Chia Chen; Mei-Yu Jang; Chuan-Sheng Wang; Kun-Bow Tsai; Shu-Hui Chuang; Huang-Chi Chen; Jer-Ming Chang
Journal:  Ann Pharmacother       Date:  2009-02-03       Impact factor: 3.154

View more
  9 in total

1.  Cocaine-induced leg ulceration.

Authors:  Khaled Shawwa; Abdul Hamid Alraiyes; Naseem Eisa; M Chadi Alraies
Journal:  BMJ Case Rep       Date:  2013-08-30

Review 2.  Cocaine-Levamisole-Induced Vasculitis/Vasculopathy Syndrome.

Authors:  Javier Marquez; Lina Aguirre; Carolina Muñoz; Andres Echeverri; Mauricio Restrepo; Luis F Pinto
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

Review 3.  Systemic sclerosis induced by the use of cocaine: is there an association?

Authors:  Rafael Andreussi; Lila Morena Bueno Silva; Henrique Carriço da Silva; Ana Paula Luppino-Assad; Danieli Castro O Andrade; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2018-12-15       Impact factor: 2.631

Review 4.  Anti-neutrophil cytoplasmic antibodies and their clinical significance.

Authors:  Supaporn Suwanchote; Muanpetch Rachayon; Pongsawat Rodsaward; Jongkonnee Wongpiyabovorn; Tawatchai Deekajorndech; Helen L Wright; Steven W Edwards; Michael W Beresford; Pawinee Rerknimitr; Direkrit Chiewchengchol
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

Review 5.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

Review 6.  Stimulants and the lung : review of literature.

Authors:  Will Tseng; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 7.  Pathologic manifestations of levamisole-adulterated cocaine exposure.

Authors:  Amber L Nolan; Kuang-Yu Jen
Journal:  Diagn Pathol       Date:  2015-05-06       Impact factor: 2.644

8.  Antineutrophil cytoplasmic antibodies crescentic allograft glomerulonephritis after sofosbuvir therapy.

Authors:  Shilpa Gadde; Belinda Lee; Laura Kidd; Rubin Zhang
Journal:  World J Nephrol       Date:  2016-11-06

Review 9.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.